CYTEK BIOSCIENCES INC. - COMMON STOCK

Cytek Biosciences Reports Second Quarter 2023 Financial Results

08 Aug 2023 15:05:01 By Nasdaq GlobeNewswire

Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023

20 Jul 2023 16:26:35 By Nasdaq GlobeNewswire

Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference

31 May 2023 15:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program

19 May 2023 08:00:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward

16 May 2023 07:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences Reports First Quarter 2023 Financial Results

09 May 2023 15:05:03 By Nasdaq GlobeNewswire

Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023

20 Apr 2023 15:05:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Introduces New 20-Color AML Panel

07 Mar 2023 16:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results

28 Feb 2023 15:05:01 By Nasdaq GlobeNewswire

Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed

28 Feb 2023 08:21:38 By Nasdaq GlobeNewswire

Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

13 Feb 2023 15:07:03 By Nasdaq GlobeNewswire

Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

07 Feb 2023 15:05:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

07 Feb 2023 08:00:02 By Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

06 Feb 2023 15:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference

21 Nov 2022 15:05:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Introduces Cytek Cloud

15 Nov 2022 09:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences Reports Third Quarter 2022 Financial Results

09 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Cytek® Biosciences Names Chris Williams Chief Operating Officer

31 Oct 2022 15:30:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022

26 Oct 2022 15:05:00 By Nasdaq GlobeNewswire

Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare Conference

30 Aug 2022 15:05:00 By Nasdaq GlobeNewswire